Unnatural amino acid orthogonal translation: a genetic engineering technology for the development of new-type live viral vaccine.
- Author:
Ruiyang LI
1
;
Zhiguang RAN
2
;
Lianzhao LUO
1
;
Anfei LI
1
;
Liting CAO
1
;
Yue MA
1
Author Information
- Publication Type:Journal Article
- Keywords: genetic engineering; orthogonal translation machinery; replication-deficient virus; unnatural amino acid; vaccine
- MeSH: Amino Acids; genetics; Amino Acyl-tRNA Synthetases; Genetic Engineering; Protein Engineering; RNA, Transfer; Viral Vaccines
- From: Chinese Journal of Biotechnology 2020;36(5):891-898
- CountryChina
- Language:Chinese
- Abstract: Unnatural amino acid orthogonal translation machinery can insert unnatural amino acids at desired sites of protein through stop codon by means of foreign orthogonal translation system composed of aminoacyl-tRNA synthetase and orthogonal tRNA genes. This new genetic engineering technology is not only a new tool for biochemical researches of proteins, but also an epoch-making technology for the development of new-type live viral vaccines. The mutated virus containing premature termination codon in genes necessary for replication can be propagated in transgenic cells harboring unnatural amino acid orthogonal translation machinery in media with corresponding unnatural amino acid, but it cannot replicate in conventional host cells. This replication-deficient virus is a new-type of live viral vaccine that possesses advantages of high efficacy of traditional attenuated vaccine and high safety of killed vaccine. This article reviews the application and prospect of unnatural amino acid orthogonal translation machinery in the development of novel replication-deficient virus vaccines.
